bullish
Industry Report: Insights on China IVD Industry - The POCT Market
208 Views04 Feb 2021 09:40
The article analyzed China POCT market in terms of market potential, market segmentations (infectious diseases, cardiac biomarkers,diabetes,blood gas/electrolyte) and related investment opportunities.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Pre-IPO Chaoju Eye Care Holdings - Here Are the Strength and the Concerns02 Mar 2021
- Beijing Wantai Biological (603392.CH) - After A 3839% Rally, Let's Look at Some Concerns28 Feb 2021
- Kingmed Diagnostics (603882 CH) Vs Dian Diagnostics (300244 CH) - Which One Is Better?18 Feb 2021
- Industry Report - Insights on China Vaccine Industry28 Jan 2021
- Industry Report - Insights on China IVD Industry06 Jan 2021
- Industry Report - Insights on China Medical Beauty Industry29 Dec 2020
x